Scleromyositis or the PM/Scl overlap syndrome is a complex autoimmune disease (a disease in which the immune system attacks the body). Patients with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis, and is therefore considered an overlap syndrome. Although it is a rare disease, it is one of the more common overlap syndromes seen in scleroderma patients, together with MCTD and synthetase syndrome.

PropertyValue
dbpprop:abstract
  • Scleromyositis or the PM/Scl overlap syndrome is a complex autoimmune disease (a disease in which the immune system attacks the body). Patients with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis, and is therefore considered an overlap syndrome. Although it is a rare disease, it is one of the more common overlap syndromes seen in scleroderma patients, together with MCTD and synthetase syndrome. Autoantibodies often found in these patients are the anti-PM/Scl antibodies.
  • L'escleromiocitis o la síndrome de solapament PM/Scl és una malaltia autoimmunitària. Tot i ser una malaltia poc freqüent, és un dels síndromes de superposició més comunes vistes en pacients amb esclerodèrmia, juntament amb la MCTD i la síndrome de sintetasa. Els autoanticossos d'aquests pacients sovint són els anti-PM/Scl (anti-exosome).
dbpprop:hasPhotoCollection
rdf:type
rdfs:comment
  • Scleromyositis or the PM/Scl overlap syndrome is a complex autoimmune disease (a disease in which the immune system attacks the body). Patients with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis, and is therefore considered an overlap syndrome. Although it is a rare disease, it is one of the more common overlap syndromes seen in scleroderma patients, together with MCTD and synthetase syndrome.
  • L'escleromiocitis o la síndrome de solapament PM/Scl és una malaltia autoimmunitària. Tot i ser una malaltia poc freqüent, és un dels síndromes de superposició més comunes vistes en pacients amb esclerodèrmia, juntament amb la MCTD i la síndrome de sintetasa. Els autoanticossos d'aquests pacients sovint són els anti-PM/Scl (anti-exosome).
rdfs:label
  • Scleromyositis
  • Escleromiositis
owl:sameAs
skos:subject
foaf:page
is dbpprop:redirect of
is owl:sameAs of